HEADER SIGNALING PROTEIN 07-JUN-17 5XR8 TITLE CRYSTAL STRUCTURE OF THE HUMAN CB1 IN COMPLEX WITH AGONIST AM841 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CANNABINOID RECEPTOR 1,FLAVODOXIN,CANNABINOID RECEPTOR 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 99-306,UNP RESIDUES 3-148,UNP RESIDUES 332- COMPND 5 414,UNP RESIDUES 99-306,UNP RESIDUES 3-148,UNP RESIDUES 332-414,UNP COMPND 6 RESIDUES 99-306,UNP RESIDUES 3-148,UNP RESIDUES 332-414; COMPND 7 SYNONYM: CB1,CANN6,CB1,CANN6; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, DESULFOVIBRIO VULGARIS (STRAIN SOURCE 3 HILDENBOROUGH / ATCC 29579 / DSM 644 / NCIMB 8303); SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606, 882; SOURCE 6 STRAIN: HILDENBOROUGH / ATCC 29579 / DSM 644 / NCIMB 8303; SOURCE 7 GENE: CNR1, CNR, DVU_2680; SOURCE 8 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 10 EXPRESSION_SYSTEM_CELL_LINE: HEK293F KEYWDS MEMBRANE PROTEIN, HUMAN G PROTEIN-COUPLED RECEPTOR, STABILIZING KEYWDS 2 AGONISTS, LIPIDIC CUBIC PHASE, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR T.HUA,K.VEMURI,P.S.NIKAS,R.B.LAPRAIRIE,Y.WU,L.QU,M.PU,A.KORDE,J.SHAN, AUTHOR 2 J.H.HO,G.W.HAN,K.DING,X.LI,H.LIU,M.A.HANSON,S.ZHAO,L.M.BOHN, AUTHOR 3 A.MAKRIYANNIS,R.C.STEVENS,Z.J.LIU REVDAT 8 22-NOV-23 5XR8 1 REMARK REVDAT 7 22-JAN-20 5XR8 1 COMPND SOURCE JRNL REMARK REVDAT 7 2 1 DBREF SEQADV HETNAM FORMUL REVDAT 7 3 1 HELIX SHEET ATOM REVDAT 6 08-NOV-17 5XR8 1 SOURCE REVDAT 5 18-OCT-17 5XR8 1 REMARK REVDAT 4 16-AUG-17 5XR8 1 REMARK REVDAT 3 09-AUG-17 5XR8 1 JRNL REVDAT 2 19-JUL-17 5XR8 1 JRNL REVDAT 1 12-JUL-17 5XR8 0 JRNL AUTH T.HUA,K.VEMURI,S.P.NIKAS,R.B.LAPRAIRIE,Y.WU,L.QU,M.PU, JRNL AUTH 2 A.KORDE,S.JIANG,J.H.HO,G.W.HAN,K.DING,X.LI,H.LIU,M.A.HANSON, JRNL AUTH 3 S.ZHAO,L.M.BOHN,A.MAKRIYANNIS,R.C.STEVENS,Z.J.LIU JRNL TITL CRYSTAL STRUCTURES OF AGONIST-BOUND HUMAN CANNABINOID JRNL TITL 2 RECEPTOR CB1. JRNL REF NATURE V. 547 468 2017 JRNL REFN ESSN 1476-4687 JRNL PMID 28678776 JRNL DOI 10.1038/NATURE23272 REMARK 2 REMARK 2 RESOLUTION. 2.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.48 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 88.2 REMARK 3 NUMBER OF REFLECTIONS : 13329 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.256 REMARK 3 R VALUE (WORKING SET) : 0.255 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.640 REMARK 3 FREE R VALUE TEST SET COUNT : 618 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.4866 - 4.6819 0.96 3613 177 0.2249 0.2420 REMARK 3 2 4.6819 - 3.7165 0.92 3282 155 0.2665 0.2671 REMARK 3 3 3.7165 - 3.2468 0.86 3046 159 0.3197 0.3998 REMARK 3 4 3.2468 - 2.9500 0.78 2770 127 0.3858 0.4094 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.480 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 43.260 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 3491 REMARK 3 ANGLE : 0.484 4764 REMARK 3 CHIRALITY : 0.036 561 REMARK 3 PLANARITY : 0.003 600 REMARK 3 DIHEDRAL : 15.503 2016 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 102 THROUGH 306 ) REMARK 3 ORIGIN FOR THE GROUP (A): -46.5828-149.0927 305.7149 REMARK 3 T TENSOR REMARK 3 T11: 0.4816 T22: 0.3626 REMARK 3 T33: 0.7640 T12: 0.0670 REMARK 3 T13: -0.0421 T23: -0.0210 REMARK 3 L TENSOR REMARK 3 L11: 5.2421 L22: 1.1492 REMARK 3 L33: 2.9624 L12: 1.0127 REMARK 3 L13: 0.3310 L23: 0.3575 REMARK 3 S TENSOR REMARK 3 S11: 0.2469 S12: 0.3485 S13: 0.0282 REMARK 3 S21: 0.0083 S22: 0.1019 S23: 0.3089 REMARK 3 S31: 0.1342 S32: -0.2645 S33: -0.3070 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 307 THROUGH 335 ) REMARK 3 ORIGIN FOR THE GROUP (A): -35.983 -118.941 259.680 REMARK 3 T TENSOR REMARK 3 T11: 0.8387 T22: 0.6905 REMARK 3 T33: 1.5988 T12: -0.0400 REMARK 3 T13: 0.0550 T23: -0.0071 REMARK 3 L TENSOR REMARK 3 L11: 8.3074 L22: 7.2240 REMARK 3 L33: 5.4565 L12: -4.1474 REMARK 3 L13: 2.7337 L23: -4.6072 REMARK 3 S TENSOR REMARK 3 S11: -0.4097 S12: -0.1339 S13: 0.3508 REMARK 3 S21: 1.0589 S22: 0.0256 S23: -0.4847 REMARK 3 S31: -0.4268 S32: -0.1613 S33: 0.4333 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 336 THROUGH 536 ) REMARK 3 ORIGIN FOR THE GROUP (A): -41.886 -126.754 276.328 REMARK 3 T TENSOR REMARK 3 T11: 0.7203 T22: 0.6250 REMARK 3 T33: 0.8890 T12: -0.0255 REMARK 3 T13: 0.1857 T23: -0.0245 REMARK 3 L TENSOR REMARK 3 L11: 2.7720 L22: 2.1089 REMARK 3 L33: 4.3409 L12: 0.5375 REMARK 3 L13: 1.3216 L23: 2.9628 REMARK 3 S TENSOR REMARK 3 S11: -0.2097 S12: 0.0659 S13: 0.2704 REMARK 3 S21: 0.3455 S22: -0.1191 S23: 1.0514 REMARK 3 S31: -0.6220 S32: 0.1866 S33: 0.3059 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THERE ARE SOME UNKNOWN DENSITIES LOCATED REMARK 3 AT THE END OF THE SIDE CHAIN OF SER152, WHICH MIGHT BE REMARK 3 PHOSPHORYLATION REMARK 3 BUT NOT CHEMICALLY CONFIRMED YET. THEY HAVE NOT BEEN MODELLED; DUE REMARK 3 TO LACK OF DENSITIES, LAST TWO C AND S ATOMS IN THE TAIL OF THE REMARK 3 LIGAND 8D0 HAS BEEN DELETED DURING THE FINAL REFINEMENT. REMARK 4 REMARK 4 5XR8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 15-JUN-17. REMARK 100 THE DEPOSITION ID IS D_1300004013. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-NOV-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13367 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.950 REMARK 200 RESOLUTION RANGE LOW (A) : 49.480 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.2 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.0600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.49000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.970 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5TGZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM CACODYLATE TRIHYDRATE PH REMARK 280 6.2, 120 MM C6H5NA3O7, 30% PEG400 AND 100 MM GLYCINE, LIPIDIC REMARK 280 CUBIC PHASE, TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,-Y,-Z+1/2 REMARK 290 4555 -X+1/2,-Y,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 33.41500 REMARK 290 SMTRY2 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 69.82000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 33.41500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 69.82000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT THE BIOLOGICAL UNIT IS UNKNOWN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 99 REMARK 465 GLU A 100 REMARK 465 ASN A 101 REMARK 465 PRO A 454 REMARK 465 ASP A 455 REMARK 465 GLN A 456 REMARK 465 ALA A 457 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 102 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 148 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 183 CG CD CE NZ REMARK 470 LYS A 308 CG CD CE NZ REMARK 470 LEU A 379 CG CD1 CD2 REMARK 470 GLU A 385 CG CD OE1 OE2 REMARK 470 LYS A 392 CG CD CE NZ REMARK 470 ARG A 450 CZ NH1 NH2 REMARK 470 ILE A 453 CG1 CG2 CD1 REMARK 470 ARG A 458 CG CD NE CZ NH1 NH2 REMARK 470 MET A 459 CG SD CE REMARK 470 ARG A 522 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 524 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS A 257 SG CYS A 264 1.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 261 97.33 -64.29 REMARK 500 SER A 315 80.52 56.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 8D0 A 1202 DBREF 5XR8 A 99 306 UNP P21554 CNR1_HUMAN 99 306 DBREF 5XR8 A 308 453 UNP P00323 FLAV_DESVH 3 148 DBREF 5XR8 A 356 536 UNP P21554 CNR1_HUMAN 332 414 SEQADV 5XR8 ALA A 210 UNP P21554 THR 210 ENGINEERED MUTATION SEQADV 5XR8 LYS A 273 UNP P21554 GLU 273 ENGINEERED MUTATION SEQADV 5XR8 VAL A 283 UNP P21554 THR 283 ENGINEERED MUTATION SEQADV 5XR8 ALA A 307 UNP P21554 LINKER SEQADV 5XR8 TRP A 403 UNP P00323 TYR 98 ENGINEERED MUTATION SEQADV 5XR8 GLU A 462 UNP P21554 ARG 340 ENGINEERED MUTATION SEQRES 1 A 438 GLY GLU ASN PHE MET ASP ILE GLU CYS PHE MET VAL LEU SEQRES 2 A 438 ASN PRO SER GLN GLN LEU ALA ILE ALA VAL LEU SER LEU SEQRES 3 A 438 THR LEU GLY THR PHE THR VAL LEU GLU ASN LEU LEU VAL SEQRES 4 A 438 LEU CYS VAL ILE LEU HIS SER ARG SER LEU ARG CYS ARG SEQRES 5 A 438 PRO SER TYR HIS PHE ILE GLY SER LEU ALA VAL ALA ASP SEQRES 6 A 438 LEU LEU GLY SER VAL ILE PHE VAL TYR SER PHE ILE ASP SEQRES 7 A 438 PHE HIS VAL PHE HIS ARG LYS ASP SER ARG ASN VAL PHE SEQRES 8 A 438 LEU PHE LYS LEU GLY GLY VAL THR ALA SER PHE THR ALA SEQRES 9 A 438 SER VAL GLY SER LEU PHE LEU ALA ALA ILE ASP ARG TYR SEQRES 10 A 438 ILE SER ILE HIS ARG PRO LEU ALA TYR LYS ARG ILE VAL SEQRES 11 A 438 THR ARG PRO LYS ALA VAL VAL ALA PHE CYS LEU MET TRP SEQRES 12 A 438 THR ILE ALA ILE VAL ILE ALA VAL LEU PRO LEU LEU GLY SEQRES 13 A 438 TRP ASN CYS GLU LYS LEU GLN SER VAL CYS SER ASP ILE SEQRES 14 A 438 PHE PRO HIS ILE ASP LYS THR TYR LEU MET PHE TRP ILE SEQRES 15 A 438 GLY VAL VAL SER VAL LEU LEU LEU PHE ILE VAL TYR ALA SEQRES 16 A 438 TYR MET TYR ILE LEU TRP LYS ALA HIS SER HIS ALA VAL SEQRES 17 A 438 ALA LYS ALA LEU ILE VAL TYR GLY SER THR THR GLY ASN SEQRES 18 A 438 THR GLU TYR THR ALA GLU THR ILE ALA ARG GLU LEU ALA SEQRES 19 A 438 ASP ALA GLY TYR GLU VAL ASP SER ARG ASP ALA ALA SER SEQRES 20 A 438 VAL GLU ALA GLY GLY LEU PHE GLU GLY PHE ASP LEU VAL SEQRES 21 A 438 LEU LEU GLY CYS SER THR TRP GLY ASP ASP SER ILE GLU SEQRES 22 A 438 LEU GLN ASP ASP PHE ILE PRO LEU PHE ASP SER LEU GLU SEQRES 23 A 438 GLU THR GLY ALA GLN GLY ARG LYS VAL ALA CYS PHE GLY SEQRES 24 A 438 CYS GLY ASP SER SER TRP GLU TYR PHE CYS GLY ALA VAL SEQRES 25 A 438 ASP ALA ILE GLU GLU LYS LEU LYS ASN LEU GLY ALA GLU SEQRES 26 A 438 ILE VAL GLN ASP GLY LEU ARG ILE ASP GLY ASP PRO ARG SEQRES 27 A 438 ALA ALA ARG ASP ASP ILE VAL GLY TRP ALA HIS ASP VAL SEQRES 28 A 438 ARG GLY ALA ILE PRO ASP GLN ALA ARG MET ASP ILE GLU SEQRES 29 A 438 LEU ALA LYS THR LEU VAL LEU ILE LEU VAL VAL LEU ILE SEQRES 30 A 438 ILE CYS TRP GLY PRO LEU LEU ALA ILE MET VAL TYR ASP SEQRES 31 A 438 VAL PHE GLY LYS MET ASN LYS LEU ILE LYS THR VAL PHE SEQRES 32 A 438 ALA PHE CYS SER MET LEU CYS LEU LEU ASN SER THR VAL SEQRES 33 A 438 ASN PRO ILE ILE TYR ALA LEU ARG SER LYS ASP LEU ARG SEQRES 34 A 438 HIS ALA PHE ARG SER MET PHE PRO SER HET FMN A1201 31 HET 8D0 A1202 29 HET CLR A1203 28 HET PEG A1204 7 HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM 8D0 (6~{A}~{R},9~{R},10~{A}~{R})-9-(HYDROXYMETHYL)-3-(8- HETNAM 2 8D0 ISOTHIOCYANATO-2-METHYL-OCTAN-2-YL)-6,6-DIMETHYL- HETNAM 3 8D0 6~{A},7,8,9,10,10~{A}-HEXAHYDROBENZO[C]CHROMEN-1-OL HETNAM CLR CHOLESTEROL HETNAM PEG DI(HYDROXYETHYL)ETHER HETSYN FMN RIBOFLAVIN MONOPHOSPHATE FORMUL 2 FMN C17 H21 N4 O9 P FORMUL 3 8D0 C26 H39 N O3 S FORMUL 4 CLR C27 H46 O FORMUL 5 PEG C4 H10 O3 FORMUL 6 HOH *(H2 O) HELIX 1 AA1 ILE A 105 MET A 109 5 5 HELIX 2 AA2 ASN A 112 SER A 146 1 35 HELIX 3 AA3 TYR A 153 VAL A 179 1 27 HELIX 4 AA4 SER A 185 ARG A 220 1 36 HELIX 5 AA5 ALA A 223 VAL A 228 1 6 HELIX 6 AA6 THR A 229 GLY A 254 1 26 HELIX 7 AA7 ASP A 272 VAL A 306 1 35 HELIX 8 AA8 GLY A 318 GLY A 335 1 18 HELIX 9 AA9 ASP A 375 SER A 382 1 8 HELIX 10 AB1 LEU A 383 THR A 386 5 4 HELIX 11 AB2 CYS A 407 GLY A 421 1 15 HELIX 12 AB3 ALA A 438 ALA A 452 1 15 HELIX 13 AB4 ASP A 460 PHE A 490 1 31 HELIX 14 AB5 ASN A 494 TYR A 519 1 26 HELIX 15 AB6 SER A 523 MET A 533 1 11 SHEET 1 AA1 5 TYR A 336 ASP A 342 0 SHEET 2 AA1 5 ALA A 307 TYR A 313 1 N ALA A 309 O GLU A 337 SHEET 3 AA1 5 LEU A 357 GLY A 361 1 O LEU A 359 N LEU A 310 SHEET 4 AA1 5 VAL A 393 GLY A 399 1 O ALA A 394 N LEU A 360 SHEET 5 AA1 5 LEU A 429 ASP A 432 1 O ILE A 431 N GLY A 399 CRYST1 66.830 73.610 139.640 90.00 90.00 90.00 P 21 2 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014963 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013585 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007161 0.00000